Study objective: We identify and characterize factors related to subsequent emergency revisits among children hospitalized for asthma.
INTRODUCTION
Asthma is the most common chronic disease in pediatrics, affecting approximately 7 million children in the United States. 1 Annually, there are 670,000 emergency department (ED) visits for acute asthma exacerbations for children nationally. 2 Reasons for asthma-related ED utilization vary, but children more frequently present to the ED rather than to a primary care provider because of partly controlled or uncontrolled asthma, 3, 4 caregiver perception of acute severity, 5 or lack of access to a medical home. 6 Moreover, returning to the ED has been shown to be common after an initial emergency visit for an acute asthma exacerbation. 7, 8 In fact, asthma is the most common diagnosis for patients with greater than or equal to 4 emergency visits in a 12-month span. 9 As many as 37% of children return to the ED within 6 months of their initial ED visit. 10, 11 Children of minority race and those with public insurance, history of asthma-related ED visit or hospitalization, and suboptimal asthma control are more likely to visit (and revisit) the ED. [12] [13] [14] [15] [16] [17] [18] [19] However, many studies describing risks related to ED utilization and reutilization have minimal patient-level data beyond these basic factors, elements that may aid in the discovery of modifiable ways to reduce asthma morbidity. [20] [21] [22] [23] Detailed patient-level predictors, including environmental exposures to tobacco 24 or traffic, 25 access to primary care, 26 and specific financial and social hardships, 27 have been shown to affect a patient's risk of asthma-related rehospitalization after an index hospitalization. The effect of these measures on ED revisit after hospitalization is less clear. Additionally, all patients with ED visits do not have equally urgent symptoms; some could be categorized as truly urgent and
Editor's Capsule Summary
What is already known on this topic Most studies examining emergency department (ED) utilization for asthma are retrospective and do not have patient-level and environmental data.
What question this study addressed
What factors are associated with ED and urgent care utilization after an asthma hospitalization?
What this study adds to our knowledge In this study of 671 children, socioeconomic status, access to primary care, and exposure-related risk factors typically predictive of asthma morbidity were not associated with ED revisit utilization.
How this is relevant to clinical practice ED visits for asthma after hospitalization are common and may be related to severity of disease. others nonurgent. 28 Traditional methods for identifying revisits (such as with International Classification of Diseases, Ninth Revision [ICD-9]/ICD-10 codes) do not yield insight into this severity of illness on presentation.
Thus, we first sought to characterize specific patientlevel characteristics, including environmental exposures, access to care, and hardships, with risk of subsequent emergency revisits among children with an asthma-related index hospitalization. Second, we sought to describe the type of asthma-related revisit (ie, acute exacerbation versus nonacute asthma related). Finally, given well-documented disparities by race (higher ED utilization by black children), we examined racial differences in frequency of emergency revisits and severity at presentation.
MATERIALS AND METHODS Study Design and Selection of Participants
The Greater Cincinnati Asthma Risk Study (GCARS) is a prospective population-based cohort study of children hospitalized for asthma and receiving oral steroids and b-agonists at Cincinnati Children's Hospital Medical Center (CCHMC) between August 2010 and October 2011. 27 For children aged 2 to 16 years, we evaluated emergency revisits subsequent to the index admission occurring during the following 12 months. Although GCARS enrolled children aged 1 to 2 years, we included in these analyses only patients older than 2 years to exclude any potential patients with bronchiolitis or nonasthma viral wheeze. Children were excluded from GCARS if the inpatient physician thought a diagnosis other than asthma was more likely and removed them from the asthma clinical pathway. Children were also excluded if they had significant nonasthma respiratory or cardiovascular disease (eg, cystic fibrosis, congenital heart disease), if they resided outside of CCHMC's 8-county primary service area, or if their primary caregiver did not understand written or spoken English (z2% of study sample). Further details on GCARS enrollment have been previously published. 27 GCARS was approved by the CCHMC institutional review board.
Setting
CCHMC is a tertiary care academic medical center with greater than or equal to 140,000 annual emergency visits to the ED and urgent care sites combined. The locations at which patients may seek emergency care include an urban ED, a suburban ED, and 5 urgent care sites; all sites share a single electronic health record. Initial treatment for asthma at all 7 locations is protocolized and aligned with National Heart, Lung, and Blood Institute recommendations. 20 Urgent care patients who require additional treatment are transferred to one of the 2 ED locations for continued outpatient care or admitted to CCHMC for inpatient care.
Outcome Measures
The primary outcome was any asthma-related emergency revisit (to any of the 7 locations) within 12 months of the patient's index hospitalization. Emergency revisits were included in the outcome if the patient was readmitted or discharged home. Revisits were classified as acute exacerbations or nonacute asthma-related revisits (defined below). We chose a period of 12 months because of the chronicity of asthma, as well as its seasonal variation. Therefore, all patients were at risk for an emergency revisit for an entire year (across all seasons). For patients with multiple asthma-related revisits, the first one was included in this analysis. Secondary outcomes included severity of illness on emergency revisit presentation and the total number of asthma-related emergency visits.
Revisit data were obtained through a review of the electronic medical record. We examined revisits to determine whether they were asthma related and whether they were acute or nonacute. Revisits with any of the following were examined: ICD-9 code for asthma (493.XX) or wheeze (786.07), respiratory chief complaint, an albuterol order (administered, dispensed, or prescribed), or an order for systemic corticosteroids (administered or prescribed). We defined asthma-related emergency revisits (primary outcome) as those in which medications for asthma (either albuterol or systemic corticosteroids) were administered during the revisit or prescribed at discharge.
Other revisits, including those that may have had an ICD-9 code for asthma but had no medications provided for asthma, were considered not asthma related and not included.
Once identified as asthma related, revisits were objectively dichotomized as acute exacerbations or nonacute asthma revisits according to the medications or prescriptions the patients received. Acute exacerbation revisits were defined as those including systemic corticosteroids as part of the treatment plan. 29 This approach is consistent with that in previous literature, in which an expert working group defined an asthma exacerbation as "a worsening of asthma requiring the use of systemic corticosteroids to prevent a serious outcome." 29 Patients with documentation of systemic corticosteroids within the preceding 24 hours of the emergency revisit were also included in the acute exacerbation revisit category. Nonacute asthma revisits were defined as those in which the patient received either an albuterol dose or prescription but did not have systemic corticosteroids included as part of the treatment plan. This approach is consistent with previous literature in regard to categorization of an emergency visit as "asthma related" according to documented asthma medications administered or prescribed at the visit. 30 Neither parental nor physician subjective impression of symptom severity was a factor in the categorization of revisits.
The range of severity for acute exacerbation revisits was then classified as mild, moderate, or severe to elucidate the necessity or potential preventability of the revisit. Severity was assessed through the first documented respiratory rate, oxygen saturation, and a respiratory score used at CCHMC. The respiratory score ranges from 0 to 8, according to physical examination findings of wheezing, air movement, respiratory rate (adjusted for age), accessory muscle use, and prolongation of expiration. 31 Initial respiratory scores of less than or equal to 2 are clinically considered to be absent or mild exacerbations, scores of 3 to 5 are considered moderate exacerbations, and those greater than or equal to 6 are considered severe exacerbations. Standard criteria for discharge to home include respiratory scores less than or equal to 2 after a period of observation after initial treatment for asthma symptoms.
We obtained detailed data on patient characteristics from a face-to-face survey with the primary caregivers for all enrolled patients during the index hospitalization. Caregivers reported basic demographic and socioeconomic information about the patient and family (eg, patient age, sex, insurance, race, caregiver income, educational attainment). Questions also assessed past use of inhaled corticosteroids as a marker of asthma severity, caregiver work or school schedule, and markers of financial and social hardships. 27 Perceived access to medical care was evaluated by the access subscale of the Parents' Perceptions of Primary Care scale. 32 We scored the subscale as previously described, 26 with an average score corresponding to "always adequate" as perfect (score¼100), average score corresponding to "almost always adequate" (score 75 to 99), or average score corresponding to "often/sometimes/ never adequate" (score <75). We also collected salivary cotinine to obtain an objective measure of secondhand tobacco exposure in the home or car environment. Salivary cotinine is a metabolite of nicotine with a half-life of approximately 16 hours. 33 Details of the collection and processing of specimens have been described previously. 24 Finally, traffic-related air pollution was quantified with a land-use regression model that allows estimation of exposure at the patient's street address. 25, 34, 35 Primary Data Analysis
We used descriptive statistics to illustrate frequencies of asthma-related emergency revisits (total, acute exacerbations, and nonacute revisits). We also classified severity on presentation for the revisits classified as acute. We performed logistic regression analyses to examine the association of patient characteristics with asthma-related emergency revisits. Nearly all predictors and covariates were included in our multivariable analyses. Models did not include the questions about visiting or calling the primary care provider because these were thought to be conceptually related to the Parents' Perceptions of Primary Care scale. We also did not include source of usual asthma care because a caregiver report of using the ED for asthma seemed less useful. Finally, caregiver work or school schedule was excluded from multivariable analysis because this factor was considered to be exploratory and was not found to be significant in bivariate analysis. We also performed additional sensitivity analyses modeling time to first emergency revisit, using Cox proportional hazards. Given documented racial disparities for ED visitation after hospitalization, we performed bivariate analyses to investigate severity of illness of acute asthma revisits by race. Finally, given the paradoxic relationship between access to care and asthma use, we performed a post hoc descriptive analysis of how access was rated by source of asthma care. All analyses were performed with SAS (version 9.3; SAS Institute, Inc., Cary, NC).
RESULTS
Of the 671 enrolled children, most were aged 4 to 11 years (59%), boys (65%), black (59%), and publicly further review, 459 (82%) of these visits were found to be consistent with visits in which children received care consistent with treatment for asthma. The remaining visits were for different concerns (eg, broken arm), but asthma was included in billing codes. The majority of asthmarelated revisits (n¼372; 81%) were classified as acute exacerbations according to our a priori definition (receiving systemic corticosteroids) (Figure 1 ). No revisits were planned. Of the 372 emergency revisits classified as acute, the majority (73%) were classified as moderate to severe exacerbation ( Figure 1) . A 25% subsample of all patients enrolled was contacted by telephone approximately 12 months after the index admission to assess potential loss to follow-up or ED utilization at non-CCHMC sites. 27 Of patients who reported using the ED, 7 of 49 revisits were to non-CCHMC sites.
Multiple factors had a bivariate association with asthma-related emergency revisit in the patient-level analysis (Table 1) . For example, black children were significantly more likely to experience an emergency revisit, with an odds ratio of 2.03 (95% confidence interval [CI] 1.43 to 2.89). Similarly, patients with public insurance had increased odds of an emergency revisit (odds ratio 2.71; 95% CI 1.80 to 4.09). Younger children, lower caregiver educational attainment, and no vehicle ownership were also more likely to mean an asthma-related emergency visit. Families who reported higher income had lower odds of readmission. Increased odds of emergency revisit were also observed for children who had been receiving inhaled corticosteroids and those who reported using the ED as their usual source of asthma care. Finally, tobacco smoke exposure (ie, detectable salivary cotinine levels) showed an association with revisit in the expected direction.
In multivariable logistic regression analyses, younger children (2 to 3 years) had the highest odds of an asthma-related revisit compared with children aged 12 years or older (adjusted odds ratio 2.24; 95% CI 1.16 to 4.32) ( Table 2 ). Black children had higher odds of revisit compared with white children (adjusted odds ratio 1.67; 95% 1.04 to 2.66). Children who had not been receiving inhaled corticosteroids in the past year had lower odds of revisit compared with those who had been receiving inhaled corticosteroids (adjusted odds ratio 0.56; 95% CI 0.38 to 0.82). Contrary to what was hypothesized, however, children who reported perfect access to primary care had higher odds of revisitation compared with those with suboptimal access (adjusted odds ratio 1.89; 95% CI 1.11 to 3.21). The time-toevent sensitivity analysis revealed similar results, with age, previous steroid use, primary care access, and lower income showing significant relationships with time to first revisit.
Black children were more likely to have greater than or equal to 2 revisits within 12 months of the index hospitalization than whites (18.6% versus 10.8%) (Figure 2 ). Black children revisited earlier than white children (Figure 3 ). Hypoxia on presentation (oxygen saturation 91%) was similar between white and black children (overall, 3% were hypoxic). Presenting respiratory score (proxy for acute severity) differed by race, with 44% of visits for black children in the moderate range and 29% in the severe category compared with 53% of visits for white children in the moderate range and 11% in the severe range (P<.01). Black children were more frequently admitted to the floor (30%) or ICU (7%) than white children (floor 18%; ICU 3%; P<.05) (Figure 4) . Given the paradoxic relationship between access to care and revisits, we examined the relationship between access to care and source of care. Of the caregivers who stated their usual source of asthma care to be the ED, 14% rated their access as perfect, 38% rated it as almost always adequate, and 47% rated their access as often, sometimes, or never adequate. In contrast, of the caregivers who stated their usual source of asthma care is their primary care provider, 23% rated their access as perfect, 52% rated it as almost always adequate, and 25% rated their access as often, sometimes, or never adequate. *Model includes sex, insurance, income, caregiver education, caregiver marital status, money left over at the end of the month, vehicle ownership, salivary cotinine level, and traffic pollution.
LIMITATIONS
Our study should be considered in the context of several limitations. First, our outcome data are limited to emergency revisits in the CCHMC system; therefore, some children may have been lost to follow-up. In our 12-month follow-up, 7 of 49 people who used the ED reported using other EDs; still, our institution dominates the pediatric emergency and hospital market locally. Second, although our caregiver surveys used previously developed questions, given the face-to-face administration of the survey, caregivers' responses were subject to social desirability bias. We expect this to have been nondifferential across groups who did or did not revisit the ED. Additionally, although our respiratory scoring system is widely deployed and has been routinely used across CCHMC for more than a decade, formal validity testing has not been performed; therefore, our severity-of-illness assessments are limited to clinical care assessments. Third, the use of logistic regression yields information on correlation and not causation.
DISCUSSION
Asthma-related emergency revisits are common after hospitalization for an asthma exacerbation; more than 4 in 10 children within our cohort returned within 1 year. The majority of asthma-related revisits were for acute exacerbations necessitating treatment with systemic corticosteroids and not for nonurgent complaints. Indeed almost 3 in 4 children revisiting an emergency care site for an acute exacerbation after a hospitalization were moderately or severely ill on presentation. In multivariable analyses, young age, black race, better primary care access, and previous inhaled corticosteroid use were associated with increased odds of emergency care revisit. Surprisingly, variables including low income, detectable cotinine level, and traffic-related air pollution exposure were not found to be independently associated with our outcome.
Black children were more likely to have emergency revisits compared with white children. This finding is consistent with our previous work assessing relationships between index hospitalization and asthma-related rehospitalization. 27, 36 Moreover, bivariate analyses suggest that black children are more likely than white ones to return for asthma-related revisits multiple times. Although black children were more likely to have multiple asthma-related revisits than white children, this does not appear to be related to overuse or misuse of the emergency setting (ie, children presenting when not ill). In fact, black children on revisits had significantly higher respiratory scores on presentation and were more likely to be admitted than white children.
Children with public insurance and those with a previous prescription for inhaled corticosteroids had higher odds of emergency care revisit in multivariable logistic regression. Also, contrary to previous findings on asthma hospital readmission, 26 children with perfect primary care access scores actually had higher odds of emergency revisit in adjusted analyses. These findings may be related to severity of underlying disease. In previous work, children with "not well-controlled" asthma (as reflected by validated asthma control test scores) had an approximately 5-fold greater risk for asthma-related primary care ill visits, as well as ED visits, compared with those with well-controlled asthma. 4 Here, children who have been receiving inhaled corticosteroids in the past have higher odds of emergency revisitation; these children likely also have more severe disease, representing a type of confounding by indication. Similarly, caregivers of children who are prone to frequent emergency exacerbations may seek out easily accessible primary care providers; thus, rating of access may, too, be partially capturing asthma severity. Additionally, the Parents' Perceptions of Primary Care metric asks families to consider "the person your child sees for health care.." 32 Some patients preferentially use the ED as their source of asthma care. These caregivers may rate their access as excellent (because the ED is always open and accessible). This would be in line with our post hoc finding that 14% of children who use the ED as their source of asthma rated their access as perfect.
Our data confirm that emergency care revisits after asthma hospitalizations are common. 8 Given the movement to episode-based payments (ie, a single payment for a period of care regardless of cost accrued during that period), it is worth considering and evaluating strategies to decrease such revisits. Educating caregivers about pediatric asthma has been shown to decrease the mean number of hospitalizations and ED visits. 37 Qualitative interviews with patients and caregivers have revealed opportunities for improvement in ED discharge instructions, including use of simplified language and increased visual learning (with opportunity for demonstrations and "teach-back").
38
There are also documented cost-effective successes within communities to improve health outcomes and decrease emergency visits for asthma, 39 yet these interventions are frequently labor and time intensive, complicating their implementation on a large scale. Hospital-based discharge interventions, which include enhanced education for children with asthma, have shown mixed effects (ie, some show no difference in revisitation, some show decreased revisits, and one showed increased revisits). 40 Furthermore, increased asthma knowledge has been shown to be associated with increased odds of readmission after an asthma discharge. 41 Thus, it is unclear whether asthma education is the best intervention or whether during a severe acute illness (requiring a hospitalization or ED visit) is the best time for that education. 42 Another potential strategy to decrease emergency care visits after hospitalization may be to increase prescribing and dispensing of inhaled corticosteroids at hospital (or ED) discharge. Such a strategy has already been shown to be cost-effective in the ED setting, 43 yet in the hectic emergency environment, the additional tasks of categorizing the patient's chronic asthma control level and appropriately prescribing an inhaled corticosteroid, coupled with provision of an updated written asthma action plan, can be challenging. 7, [44] [45] [46] Locally, we have a broad ongoing asthma quality improvement collaborative to increase dispensing inhaled corticosteroids for home use in the inpatient setting when the patient is prescribed steroids. 47 Additionally, physicians are prompted to ask about long-term level of control for all children admitted with asthma. 48 Further work in ensuring that all children who would benefit from inhaled corticosteroids are prescribed them at discharge may prevent posthospital emergency health care use. Continued targeted efforts within these identified specific subpopulations (eg, those of younger age) at high risk for revisits may also be warranted, given the lack of decline of ED visits during the past decade, coupled with the high rate of revisits for asthma. 49 Emergency revisits for asthma exacerbations are common after an asthma-related hospitalization. The majority of children who revisit the ED and urgent care sites for acute asthma symptoms are experiencing exacerbations and are moderately to severely ill. Young children, black children, and those receiving inhaled steroids are at increased odds of any asthma-related emergency revisitation. Finally, socioeconomic and exposure-related risk factors typically predictive of asthma morbidity were not independently associated with emergency revisit among children in this cohort.
